Elsevier

Brain Research

Volume 629, Issue 2, 3 December 1993, Pages 260-268
Brain Research

Cholecystokinin in human cerebrospinal fluid: concentrations, dynamics, molecular forms and relationship to fasting and feeding in health, depression and alcoholism

https://doi.org/10.1016/0006-8993(93)91329-QGet rights and content

Abstract

Very little is known about the physiologic significance of the gut-brain hormone cholecystokinin (CCK) in the human central nervous system, although the hormone has been hypothesized to be involved in the regulation of both appetite and anxiety. We continuously collected lumbar cerebrospinal fluid (CSF) via indwelling subarachnoid catheters in ten normal volunteers, ten patients with major depression and five abstinent alcoholic humans, while fasting and after eating. Five other healthy subjects were fasted throughout the experiment. We quantified CSF immunoreactive cholecystokinin (IR-CCK) and glucose concentrations at 10-min intervals from 11.00 to 17.00 h. No difference in CSF IR-CCK concentration, half-life or rhythm was observed between normal volunteers and either depressed or alcoholic patients. Fasting CSF IR-CCK concentrations were 1.3 ± 0.18, 1.3 ± 0.21 and 1.2 ± 0.21 fmol/ml (mean ± S.E.M.) in normal volunteers, depressed patients and alcoholic patients, respectively. After eating, CSF IR-CCK concentrations rose to 1.5 ± 0.21, 1.5 ± 0.24 and 1.4 ± 0.26 fmol/ml, respectively. Normal volunteers who did not eat had similar basal CSF IR-CCK concentrations (1.1 ± 0.1 fmol/ml) which similarly rose to 1.4 ± 0.13 fmol/ml during the sampling interval. In contrast, CSF glucose concentrations rose only in the subjects who ate, beginning to rise after about 1 h and remaining elevated for at least 3 h after eating. These data suggest the existence of a diurnal rhythm of IR-CCK release into CSF, as opposed to a response to feeding. The disappearance half-time of CCK in human CSF is less than 13 min. The rapid intra-individual concentration transients in CSF IR-CCK concentration observed suggest pulsatile release of CCK into and rapid removal from CSF. Thus, it is likely that the IR-CCK measured in lumbar CSF is principally derived from spinal cord and does not reflect possible changes in hypothalamic IR-CCK after eating. Finally, gel filtration chromatography confirmed that IR-CCK in human CSF is heterogeneous, but, in contrast to previous studies, we found that the majority of activity is associated with a peptide(s) whose molecular weight is 1.66 kDa, corresponding in size to CCK-12 (CCK-[22-33]).

References (63)

  • PhilippE. et al.

    Cholecystokinin, gastrin and stress hormone responses in marathon runners

    Peptides

    (1992)
  • RafaelsenO.J. et al.

    Neuropeptides in cerebrospinal fluid (CSF) in psychiatric patients

    Prog. Neuro-Psychopharmacol. Biol. Psychiatry

    (1985)
  • RehfeldJ.F.

    Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog

    J. Biol. Chem.

    (1978)
  • RehfeldJ.F. et al.

    Characterization of preprocholecystokinin products in the porcine cerebral cortex: evidence of different processing pathways

    J. Biol. Chem.

    (1986)
  • RehfeldJ.F. et al.

    Gastrin and cholecystokinin in human cerebrospinal fluid. Immunochemical determinations of concentrations and molecular heterogeneity

    Brain Res.

    (1978)
  • RehfeldJ.F. et al.

    Expression, but failing maturation of procholecystokinin in cerebellum

    Brain Res.

    (1992)
  • RyderS. et al.

    Alkaline extraction and characterization of cholecystokinin-immunoreactivity from rat gut

    Gastroenterology

    (1981)
  • SchickR.R. et al.

    Neuronal cholecystokinin-like immunoreactivity is post-prandially released from primate hypothalamus

    Brain Res.

    (1987)
  • SchickR.R. et al.

    Chronic intraventricular administration of cholecystokinin octapeptide (CCK-8) suppresses feeding in rats

    Brain Res.

    (1988)
  • ShiraishiT.

    CCK as a central satiety factor: behavioral and electrophysiologic evidence

    Physiol. Behav.

    (1990)
  • VerbanckP.M.P. et al.

    Reduced cholecystokinin immunoreactivity in the cerebrospinal fluid of patients with psychiatric disorders

    Life Sci.

    (1984)
  • WolkowitzO.M. et al.

    Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist

    Biol. Psychiatry

    (1990)
  • AbuchamJ. et al.

    Regulation of cholecystokinin octapeptide secretion by rat cerebral cortical cells in primary culture

    Endocrinology

    (1991)
  • AdinoffB. et al.

    Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin releasing hormone and corticotropin levels in alcoholics after recent and long-term abstinence

    Arch. Gen. Psychiatry

    (1990)
  • American Psychiatric Association
  • BaileC.A. et al.

    Role of cholecystokinin and opioid peptides in control of food intake

    Physiol. Rev.

    (1986)
  • BenarrochE.E. et al.

    Segmental analysis of neuropeptide concentrations in normal human spinal cord

    Neurology

    (1990)
  • BradwejnJ. et al.

    Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurons

    Nature

    (1984)
  • BradwejnJ. et al.

    Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder

    Can. J. Psychiatry

    (1990)
  • BruceJ.N. et al.

    Method for sequential sampling of cerebrospinal fluid in humans

    Neurosurgery

    (1988)
  • Della-FeraM.A. et al.

    Cholecystokinin octapeptide: continuous pciomole injections into the cerebral ventricles of sheep supress feeding

    Science

    (1979)
  • Cited by (31)

    View all citing articles on Scopus
    View full text